![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Blackledge G. Sheppard A.
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.3, Iss.1, 1998-06, pp. : 303-316
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for prostate cancer
By Siddiqui Kashif Klotz Laurence H
Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for prostate cancer
By Chung Paul H Gayed Bishoy A Thoreson Gregory R Raj Ganesh V
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 4, 2013-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for colorectal cancer
By Fogelman David R Kopetz Scott Eng Cathy
Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for biliary cancer
By Eckel Florian Schmid Roland M
Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for esophageal cancer
By Homs Marjolein YV Voest Emile E Siersema Peter D
Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. :